Hepatobiliary&Pancreatic Diseases International
2022-11-24
Aims and Scope
Hepatobiliary&PancreaticDiseasesInternationalpublishes peerreviewed original papers,reviews(meta-analysis,systematic review)and editorials concerned with clinical practice and research in the fields of hepatobiliary and pancreatic diseases.Papers cover the medical,surgical,radiological,pathological,biochemical,physiological and histological aspects of the subject areas under the headings Liver,Biliary,Pancreas,Transplantation,Research,Editorials,Review Articles,New Techniques,Clinical Images,Viewpoints and Letters to the Editor.The journal also deals with the basic sciences and experimental work.All submitted papers are reviewed by at least two referees in the field of the submitted paper.For detailed instructions concerning the submission of manuscripts,please refer to the Instructions for Authors in each issue of the journal.Full articles are available at ScienceDirect.
Editorial Office
Hepatobiliary&PancreaticDiseasesInternational,the First Affiliated Hospital,Zhejiang University School of Medicine,79 Qingchun Road,Hangzhou 310003,China.Tel:+86-571-87236559,+86-571-87236600;Fax:+86-571-87236559;E-mail:hbpdint@126.com,hbpdje@zju.edu.cn.
Business Correspondence and Advertising Principles
All matters relating to orders,subscriptions,back issues,offprints,advertisement booking and general enquiries should be addressed to:Yan-Ping Dong;E-mail:hbpdint@126.com;visit our website athttp://www.hbpdint.com.Advertisements in this journal have to be reviewed to comply with the principles governing advertising in this journal.The appearance of advertising inHepatobiliary&PancreaticDiseasesInternationalis not a guarantee or endorsement of the product or the claims made for the product.
Subscription Rates
The journal is published 6 times per year and the prices for 2022 are asfollows:Institution:US$400(rest of world);Personal:US$200.The journal is despatched to subscribers outside China by surface air-lifted delivery.
Database
Hepatobiliary&PancreaticDiseasesInternationalis abstracted and indexed in Chemical Abstracts (CA), EMBASE/Excerpta Medica(EM),Index Medicus(IM)/MEDLINE,Science Citation Index Expanded(SCI-E),SCOPUS.Electronic availabilityhttp://www.hbpdint.com.The impact factor of the journal is 3.355(Clarivate Analytics 2021JournalCitationReports).
Disclaimer
The publisher,the hospital and the editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal;the views and opinions expressed do not necessarily reflect those of the publisher,the hospital or the editors,neither does the publication of advertisements constitute any endorsement by the publisher,the hospital or the editors of the products advertised.
Copyright and Photocopying
©2022Hepatobiliary&PancreaticDiseasesInternational,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China.All rights reserved.No part of this publication may be reproduced,stored,or transmitted in any form or by any means,electronic or mechanical,including photocopy,recording,or any information storage and retrieval system,without permission in writing from the owner of the journal.
∞○The paper used in this publication meets the requirements of ANSI/NISO Z39.48-1992(Permanence of Paper).
杂志排行
Hepatobiliary & Pancreatic Diseases International的其它文章
- Meetings and Courses
- Adenovirus and severe acute hepatitis of unknown etiology in children: Offender or bystander?
- Safety of rectal indomethacin (100 mg) for the prevention of post-ERCP pancreatitis in the Japanese population: A single-center prospective pilot study
- Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas mimicking pancreatic pseudocyst
- Branching patterns of the left portal vein and consequent implications in liver surgery: The left anterior sector
- Recurrent pyogenic cholangitis: An indication for liver transplantation